Urology
Volume 76, Issue 2 , Pages 515.e1-515.e7 , August 2010

Quantitative Loss of Heterozygosity Analysis for Urothelial Carcinoma Detection and Prognosis

  • Delphine Collin-Chavagnac

      Affiliations

    • Service de Biochimie et Biologie Moléculaire Sud, Centre Hospitalier Universitaire Lyon Sud, Chemin du Grand Revoyet, Pierre Bénite, Hospices Civils de Lyon, France
    • Laboratoire de Radiobiologie Cellulaire et Moléculaire, Faculté de Médecine Lyon-Sud, Université Lyon 1, Université de Lyon, Oullins, France
    • Corresponding Author InformationReprint requests: Delphine Collin-Chavagnac, Pharm.D., Service de Biochimie et Biologie Moléculaire Sud, Centre Hospitalier Universitaire Lyon Sud, 165 Chemin du Grand Revoyet, 69495 Pierre Bénite Cedex, Hospices Civils de Lyon, France
    • ,
  • Christophe Marçais

      Affiliations

    • Service de Biochimie et Biologie Moléculaire Sud, Centre Hospitalier Universitaire Lyon Sud, Chemin du Grand Revoyet, Pierre Bénite, Hospices Civils de Lyon, France
    • ,
  • Stephane Billon

      Affiliations

    • Service de Biochimie et Biologie Moléculaire Sud, Centre Hospitalier Universitaire Lyon Sud, Chemin du Grand Revoyet, Pierre Bénite, Hospices Civils de Lyon, France
    • ,
  • Françoise Descotes

      Affiliations

    • Service de Biochimie et Biologie Moléculaire Sud, Centre Hospitalier Universitaire Lyon Sud, Chemin du Grand Revoyet, Pierre Bénite, Hospices Civils de Lyon, France
    • ,
  • Eric Piaton

      Affiliations

    • Centre de Pathologie Est, Hôpital Femme-Mère-Enfant, Boulevard Pinel, Bron, France
    • ,
  • Myriam Decaussin

      Affiliations

    • Centre d'Anatomopathologie Sud, Centre Hospitalier Universitaire Lyon Sud, Chemin du Grand Revoyet, Pierre Bénite, France
    • ,
  • Claire Rodriguez-Lafrasse

      Affiliations

    • Service de Biochimie et Biologie Moléculaire Sud, Centre Hospitalier Universitaire Lyon Sud, Chemin du Grand Revoyet, Pierre Bénite, Hospices Civils de Lyon, France
    • Laboratoire de Radiobiologie Cellulaire et Moléculaire, Faculté de Médecine Lyon-Sud, Université Lyon 1, Université de Lyon, Oullins, France
    • ,
  • Alain Ruffion

      Affiliations

    • Service d'Urologie, Centre Hospitalier Universitaire Lyon Sud, Chemin du Grand Revoyet, Pierre Bénite, France

Received 7 May 2009 ,Accepted 14 November 2009.

References 

  1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  2. Sauter G, Knowles MA, Hartmann A, et al. Tumours of the genitourinary system. In:  Eble JN,  Sauter G,  Epstein JI editor. World-Health Organization Classification of Tumours (Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs). Lyon, France: IARC Press; 2004;p. 89–158
  3. Kirkali Z, Chan T, Manoharan M, et al. Bladder cancer: epidemiology, staging and grading, and diagnosis. [review] Urology. 2005;66:4–34
  4. Boman H, Hedelin H, Holmang S. Four bladder tumor markers have a disappointingly low sensitivity for small size and low grade recurrence. J Urol. 2002;167:80–83
  5. Cairns P, Shaw ME, Knowles MA. Initiation of bladder cancer may involve deletion of a tumour-suppressor gene on chromosome 9. Oncogene. 1993;8:1083–1085
  6. Cairns P, Shaw ME, Knowles MA. Preliminary mapping of the deleted region of chromosome 9 in bladder cancer. Cancer Res. 1993;53:1230–1232
  7. Oosterlinck W, Lobel B, Jakse G, et al. European Association of Urology (EAU) Working Group on Oncological Urology Guidelines on bladder cancer. Eur Urol. 2002;41:105–112
  8. Layfield LJ, Elsheikh TM, Fili A, et al. Papanicolaou Society of Cytopathology Review of the state of the art and recommendations of the Papanicolaou Society of Cytopathology for urinary cytology procedures and reporting: the Papanicolaou Society of Cytopathology Practice Guidelines Task Force. Diagn Cytopathol. 2004;30:24–30
  9. Schneider A, Borgnat S, Lang H, et al. Evaluation of microsatellite analysis in urine sediment for diagnosis of bladder cancer. Cancer Res. 2000;60:4617–4622
  10. Berger AP, Parson W, Stenzl A, et al. Microsatellite alterations in human bladder cancer: detection of tumor cells in urine sediment and tumor tissue. Eur Urol. 2002;41:532–539
  11. Kallioniemi A, Kallioniemi OP, Citro G, et al. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes Chromosomes Cancer. 1995;12:213–219
  12. Stoehr R, Zietz S, Burger M, et al. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer. Eur Urol. 2005;47:58–63
  13. von Knobloch R, Hegele A, Brandt H, et al. Serum DNA and urine DNA alterations of urinary transitional cell bladder carcinoma detected by fluorescent microsatellite analysis. Int J Cancer. 2001;94:67–72
  14. Seripa D, Parrella P, Gallucci M, et al. Sensitive detection of transitional cell carcinoma of the bladder by microsatellite analysis of cells exfoliated in urine. Int J Cancer. 2001;95:364–369
  15. Utting M, Werner W, Dahse R, et al. Microsatellite analysis of free tumor DNA in urine, serum, and plasma of patients: a minimally invasive method for the detection of bladder cancer. Clin Cancer Res. 2002;8:35–40
  16. Dal Canto M, Bartoletti R, Travaglini F, et al. Molecular urinary sediment analysis in patients with transitional cell bladder carcinoma. Anticancer Res. 2003;23:5095–5100
  17. Turyn J, Matuszewski M, Schlichtholz B. Genomic instability analysis of urine sediment versus tumor tissue in transitional cell carcinoma of the urinary bladder. Oncol Rep. 2006;15:259–265
  18. Knowles MA. Molecular pathogenesis of bladder cancer. Int J Clin Oncol. 2008;13:287–297
  19. Wu XR. Urothelial tumorigenesis: a tale of divergent pathways. Nat Rev Cancer. 2005;5:713–725
  20. Dinney CP, McConkey DJ, Millikan RE, et al. Focus on bladder cancer. Cancer Cell. 2004;6:111–116
  21. Böhle A, Jocham D, Bock PR. Intravesical bacillus Calmette-Guerin versus mitomycin C for superficial bladder cancer: a formal meta-analysis of comparative studies on recurrence and toxicity. J Urol. 2003;169:90–95
  22. Van Rhijn BW, Lurkin I, Kirkels WJ, et al. Microsatellite analysis—DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trial. Cancer. 2001;92:768–775
  23. Steiner G, Schoenberg MP, Linn JF, et al. Detection of bladder cancer recurrence by microsatellite analysis of urine. Nat Med. 1997;3:621–624
  24. Rouprêt M, Hupertan V, Yates DR, et al. A comparison of the performance of microsatellite and methylation urine analysis for predicting the recurrence of urothelial cell carcinoma, and definition of a set of markers by Bayesian network analysis. BJU Int. 2008;101:1448–1453
  25. Amira N, Mourah S, Rozet F, et al. Non-invasive molecular detection of bladder cancer recurrence. Int J Cancer. 2002;101:293–297

PII: S0090-4295(09)02994-X

doi: 10.1016/j.urology.2009.11.046

Urology
Volume 76, Issue 2 , Pages 515.e1-515.e7 , August 2010

Article Tools